Abstract
In an attempt to improve the therapeutic efficacy against liver metastases, a hepatic arterial infusion (HAI) of interleukin-2 (IL-2)-based immunochemotherapy for anticipating the regional potentiation of hepatic lymphokine-activated killer (LAK)/tumor-infiltrating lymphocytes (TIL) was initiated. We present herein the cases of three patients with multiple liver metastases from colorectal cancer in whom complete remission was achieved by treatment with an HAI of IL-2 in combination with mitomycin C (MMC) and 5 fluorouracil (5-FU). These patients received an HAI of IL-2 at 8 x 105 JRU, 5-FU at 250 mg daily, and MMC at 4 mg once weekly for 3 weeks, being the induction regimen, after which they were discharged on maintenance therapy consisting of IL-2 at 2 X 106 JRU, 5-FU at 250 mg twice weekly, and MMC at 4 mg once weekly. It was evident from the liver CT scan taken after 2–3 months that the metastatic foci seen before therapy had clearly disappeared, while the serum carcinoembryonic antigen (CEA) had decreased to normal levels in all three patients. Pancytopenia was seen in one patient, but other laboratory studies of the hepatic and renal parameters were normal. The total lymphocyte count in the peripheral blood showed a mild decrease, while the lymphocyte phenotype study showed a notable increase in CD4+ cells and a decrease in CD8+ cells, with an elevation of a 4/8 ratio, in all cases during therapy. One patient relapsed with pelvic recurrence 14 months after the initiation of therapy, but the other two patients are still in remission 25 and 22 months after the initiation of therapy.
References
Kemeny N (1987) Role of chemotherapy in the treatment of colorectal carcinoma. Semin Surg Oncol 3:190–214
Balch CM, Urist MM, Soong SJ, McGregor M (1983) A prospective phase 11 clinical trial of continuous FUdR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198:567–573
Shepard K, Levin B, Karl R (1985) Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted port. J Clin Oncol 3:161–169
Patt YZ, Chuang VP, Wallace S, Hersh EM, Freireich EJ, Mavligit GM (1981) The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver. Lancet 1:349–350
Schlag P, Hohenberger P, Holting T, Buhl K, Schwarz V, Herfarth C (1990) Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU. Eur J Surg Oncol 16:99–104
Wallace S, Humberto C, Charnsangavej C, Richli WR, Wright K, Gianturco C (1990) Hepatic artery infusion and chemoembolization in the management of liver metastases. Cardiovasc Intervent Radiol 13:153–160
Healey JE, Sheena K (1963) Vascular patterns in metastatic liver tumors. Surg Forum 14:121–122
Ackerman NB (1974) The blood supply of experimental liver metastases. Changes in vascularity with increasing tumor growth. Surgery 75:589–596
Taylor J, Bennett R, Sheriff S (1979) The blood supply of colorectal liver metastases. Br J Cancer 39:749–756
Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107:459–465
Rosenberg SA, Lotze MT, Muul LM, Change AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Eng J Med 316:889–897
Rosenberg SA (1988) Cancer therapy with interleukin-2: Immunologic manipulations can mediate the regression of cancer in humans. J Clin Oncol 6:403–406
Lotze MT, Line BR, Mathisen DJ, Rosenberg SA (1980) The invivo distribution of autologous human and murine lymphoid cells grown in T-cell growth factor (TCGF): Implications for the adoptive immunotherapy of tumors. J Immunol 125:1487–1493
Kaneda K, Dan C, Wake K (1983) Pit cells as natural killer cells. Biomed Res 4:567–576
Bouwens L, Remels L, Wisse E (1987) Large granular lymphocytes or “pit cells” from rat liver: Isolation, ultrastructural characterization and natural killer activity. Eur J Immunol 17:27–42
Wiltrout RH, Mathieson BJ, Talmadge JE, Raynolds CW, Zhang SR, Herberman R, Ortaldo JR (1984) Augmentation of organ-associated natural killer activity by biological response modifiers: Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 160:1431–1449
Zhang SR, Salup RR, Urias PE, Twilley TA, Talmadge JE, Herberman RB (1986) Augmentation of NK activity and/or macrophage-mediated cytotoxicity in the liver by biological response modifiers including human recombinant interleukin-2. Cancer Immunol Immunother 21:19–25
Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S (1984) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401
Bouwens L, Wisse E (1989) Hepatic pit cells have natural cytotoxic (NC) activity against solid tumor-derived target cells. In: Wisse E, Knook DL, Decker K (eds) The Netherlands Cells of the Hepatic Sinusoid. Rijswijk: Kupffer Cell Foundation, pp 215–220
Mavligit GM, Zukiwski AA, Gutterman JU, Salem P, Charnsangavej C, Wallace S (1990) Splenic versus hepatic artery infusion of interleukin-2 in patients with liver metastases. J Clin Oncol 8:319–324
Morikawa K, Hosokawa M, Hamada J, Xu ZI, Kobayashi H (1986) Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma. Cancer Res 46:684–688
Mihich E (1971) Preclinical evaluation of the interrelationships between cancer chemotherapy and immunity. Natl Cancer Inst Monogr 34:90–102
North RJ (1981) Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J Exp Med 155:1603–1074
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okuno, K., Ohnishi, H., Nakajima, I. et al. Complete remission of liver metastases from colorectal cancer by treatment with a hepatic artery infusion (HAI) of interleukin-2-based immunochemotherapy: reports of three cases. Surg Today 24, 80–84 (1994). https://doi.org/10.1007/BF01676892
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01676892